4
MARKET OVERVIEW
Microfluidics market poised for growth with 3D printing integration and rising precision medicine demand.
46
4.2.1.1
INTEGRATION OF MICROFLUIDICS WITH 3D PRINTING
4.2.2
E-HEALTH AND DIGITAL DIAGNOSTICS DRIVING MICROFLUIDICS ADOPTION
4.2.2.1
INCREASING PREVALENCE OF CHRONIC DISEASES FUELING POC TESTING
4.2.2.2
INCREASING FOCUS ON DATA PRECISION AND ACCURACY
4.2.3.1
REGULATORY AND CLINICAL VALIDATION BARRIERS
4.2.3.2
MATERIAL SELECTION FOR MICROFLUIDIC DEVICES
4.2.4.1
ADVANCING MICROFLUIDICS FOR REAL-TIME FOOD SAFETY MONITORING
4.2.4.2
RISING DEMAND FOR ORGAN-ON-A-CHIP PLATFORMS IN PRECISION MEDICINE
4.2.5.1
LIMITED ADOPTION OF MICROFLUIDIC DEVICES
4.2.5.2
TECHNICAL AND OPERATIONAL LIMITATIONS
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, AND AI ADOPTION
Harness AI-driven microfluidics innovations to unlock market potential and strategic patent advantages.
56
5.2
COMPLEMENTARY TECHNOLOGIES
5.2.1
MICRO-ELECTRO-MECHANICAL SYSTEMS (MEMS)
5.2.2
WEARABLE & IMPLANTABLE MICROFLUIDICS
5.3.1
INNOVATIONS AND PATENT REGISTRATIONS
5.5
IMPACT OF AI/GENAI ON MICROFLUIDICS MARKET
5.5.1
TOP USE CASES AND MARKET POTENTIAL
5.5.2
BEST PRACTICES IN MICROFLUIDICS
5.5.3
CASE STUDIES OF AI IMPLEMENTATION IN MICROFLUIDICS MARKET
5.5.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
5.5.5
CLIENT'S READINESS TO ADOPT GENERATIVE AI IN MICROFLUIDICS MARKET
5.6
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
5.7.4
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Understand stakeholder influence and unmet needs to optimize microfluidic component purchasing decisions.
73
6.1
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
6.1.1
KEY STAKEHOLDERS IN BUYING PROCESS
6.2
DECISION-MAKING PROCESS
6.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
6.4
UNMET NEEDS FROM END USERS
7
INDUSTRY TRENDS
Identify strategic opportunities in microfluidics through competitive forces and regional economic insights.
78
7.1
PORTER’S FIVE FORCES ANALYSIS
7.1.1
THREAT OF NEW ENTRANTS
7.1.2
THREAT OF SUBSTITUTES
7.1.3
BARGAINING POWER OF SUPPLIERS
7.1.4
BARGAINING POWER OF BUYERS
7.1.5
INTENSITY OF COMPETITIVE RIVALRY
7.2
MACROECONOMIC INDICATORS
7.2.2
HEALTHCARE EXPENDITURE AND INFRASTRUCTURE OUTLOOK
7.2.3
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
7.2.4
MACROECONOMIC OUTLOOK FOR EUROPE
7.2.5
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
7.2.6
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
7.2.7
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
7.2.8
TRENDS IN GLOBAL MICROFLUIDICS INDUSTRY
7.3.1
RESEARCH & DEVELOPMENT
7.3.2
RAW MATERIAL PROCUREMENT & MANUFACTURING
7.3.3
MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
7.5.1
AVERAGE SELLING PRICE TREND, BY REGION
7.5.2
AVERAGE SELLING PRICE OF MICROFLUIDIC COMPONENTS, BY KEY PLAYERS
7.6.1
IMPORT DATA (HS CODE 3822)
7.6.2
EXPORT DATA (HS CODE 3822)
7.7
KEY CONFERENCES & EVENTS, 2026-2027
7.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
7.9
INVESTMENT & FUNDING SCENARIO
7.10.1
CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
7.10.2
CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
7.10.3
CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
7.11
IMPACT OF 2025 US TARIFFS ON MICROFLUIDICS MARKET
7.11.3
PRICE IMPACT ANALYSIS
7.11.4
IMPACT ON COUNTRY/REGION
7.11.5
IMPACT ON END-USE INDUSTRIES
8
MICROFLUIDICS MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 28 Data Tables
99
8.2
MICROFLUIDICS-BASED DEVICES
8.2.1
HIGH UPTAKE OF POC TESTING AND ORGAN-ON-A-CHIP SYSTEMS TO DRIVE MARKET
8.2.2
POLYMERASE CHAIN REACTION (PCR) SYSTEMS
8.2.3
MICROFLUIDIC CAPILLARY ELECTROPHORESIS
8.2.4
NEXT-GENERATION SEQUENCING (NGS) SYSTEMS
8.2.5
DROPLET & PARTICLE PRODUCTION SYSTEMS
8.4
MICROFLUIDIC COMPONENTS
8.4.1
CRUCIAL FOR CONTINUOUS HEALTH MONITORING
8.4.2
MICROFLUIDIC COMPONENTS, BY TYPE
8.4.2.1
MICROFLUIDIC CHIPS
8.4.2.2
FLOW & PRESSURE SENSORS
8.4.2.3
FLOW & PRESSURE CONTROLLERS
8.4.2.4
MICROFLUIDIC VALVES
8.4.2.7
OTHER MICROFLUIDIC COMPONENTS
8.4.3
MICROFLUIDIC COMPONENTS, BY MATERIAL
8.4.3.2
POLYMETHYL METHACRYLATE (PMMA)
8.4.3.3
POLYDIMETHYLSILOXANE (PDMS)
8.4.3.4
CYCLIC OLEFIN COPOLYMER (COC)
9
MICROFLUIDICS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 24 Data Tables
119
9.2
IN VITRO DIAGNOSTICS (IVD)
9.2.1
CLINICAL DIAGNOSTICS
9.2.1.1
GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET
9.2.2
POINT-OF-CARE TESTING (POCT)
9.2.2.1
INCREASING DEMAND FOR DECENTRALIZED INFECTIOUS DISEASE TESTING TO DRIVE MARKET
9.2.3
VETERINARY DIAGNOSTICS
9.2.3.1
RISING DEMAND FOR RAPID, FIELD-DEPLOYABLE VETERINARY DIAGNOSTICS TO DRIVE MARKET
9.3.1.1
ABILITY TO ENABLE SCALABLE PRODUCTION OF POLYMER-BASED DRUG PARTICLES TO DRIVE MARKET
9.3.2.1
ABILITY TO ENABLE PROACTIVE MANAGEMENT OF HYDRATION, METABOLIC STATUS, AND DISEASE BIOMARKERS TO DRIVE MARKET
9.4
PHARMACEUTICAL & LIFE SCIENCE RESEARCH
9.4.1.1
PROTEOMIC ANALYSIS
9.4.1.1.1
UTILIZATION OF PROTEOMES-ON-A-CHIP DEVICES FOR THERAPEUTIC DEVELOPMENT TO DRIVE MARKET
9.4.1.2.1
HIGH-THROUGHPUT, COST-EFFECTIVE GENOMIC ANALYSIS ENABLED BY MICROFLUIDICS
9.4.1.3
CELL-BASED ASSAYS
9.4.1.3.1
MICROFLUIDIC CO-CULTURES ENABLE PRECISE, HIGH-THROUGHPUT MODELING OF COMPLEX TISSUES FOR DRUG TESTING AND DISEASE RESEARCH
9.4.1.4
CAPILLARY ELECTROPHORESIS
9.4.1.4.1
ENABLES HIGH-THROUGHPUT, PRECISE, AND COST-EFFICIENT PROTEIN AND NUCLEIC ACID ANALYSIS
9.4.2.1
SUITABILITY FOR LOW-VISCOSITY APPLICATIONS TO SUPPORT MARKET GROWTH
9.4.3.1
GROWING ADOPTION OF CONTINUOUS FLOW SYNTHESIS IN RESEARCH & DEVELOPMENT TO DRIVE MARKET
10
MICROFLUIDICS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
135
10.2
HOSPITALS & DIAGNOSTIC CENTERS
10.2.1
RISING DEPENDENCE ON RAPID MICROFLUIDIC MOLECULAR DIAGNOSTICS TO DRIVE GROWTH
10.3
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1
STRONG ADOPTION OF MICROFLUIDIC TECHNOLOGIES FOR PRECISE FORMULATION, NANOPARTICLE PRODUCTION, AND TOXICITY TESTING TO DRIVE GROWTH
10.4
ACADEMIC & RESEARCH INSTITUTES
10.4.1
INVESTMENTS IN BIOMEDICAL & LIFE SCIENCE RESEARCH TO DRIVE GROWTH
11
MICROFLUIDICS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 132 Data Tables.
141
11.2.1.1
EXPANSION OF APPLICATIONS BEYOND TRADITIONAL DIAGNOSTICS TO DRIVE MARKET
11.2.2.1
GOVERNMENT FUNDING AND COLLABORATIVE ECOSYSTEMS TO SUPPORT GROWTH
11.3.1.1
ONGOING INVESTMENTS IN SEMICONDUCTORS AND MICROELECTRONICS TO DRIVE MARKET
11.3.2.1
RISING DEMAND FOR ADVANCED LAB-ON-CHIP AND ORGAN-ON-CHIP SOLUTIONS TO DRIVE MARKET
11.3.3.1
RISING CASES OF CHRONIC DISEASES AND INCREASING DEMAND FOR POC TESTING TO BOOST DEMAND
11.3.4.1
SHIFT TOWARD COST-EFFICIENT MICROFLUIDIC PLATFORMS FOR DIAGNOSTICS, ENVIRONMENTAL TESTING, AND ADVANCED BIOMEDICAL RESEARCH TO DRIVE MARKET
11.3.5.1
INCREASING DEMAND FOR ACCESSIBLE POINT-OF-CARE AND LAB-ON-CHIP SOLUTIONS TO DRIVE MARKET
11.4.1.1
GOVERNMENT SUPPORT AND STRATEGIC PARTNERSHIPS TO DRIVE MARKET
11.4.2.1
GOVERNMENT SUPPORT, INNOVATION, AND INDUSTRY-ACADEMIA COLLABORATION TO DRIVE GROWTH
11.4.3.1
GROWING BIOTECH STARTUP ECOSYSTEM AND RESEARCH FROM PREMIER INSTITUTIONS TO DRIVE MARKET
11.4.4.1
INNOVATION ECOSYSTEM, R&D STRENGTH, AND PRECISION ENGINEERING TO SUPPORT GROWTH
11.4.5.1
ADVANCED RESEARCH, GLOBAL PARTNERSHIPS, AND NEXT-GEN TECHNOLOGIES TO DRIVE MARKET
11.4.6
REST OF ASIA PACIFIC
11.5.1.1
RISING INVESTMENT IN HEALTHTECH AND EMPHASIS ON MOLECULAR DIAGNOSTICS TO DRIVE MARKET
11.5.2.1
GROWING DEMAND FOR ADVANCED DIAGNOSTICS AND BIOTECH INNOVATION TO DRIVE MARKET
11.5.3
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.6.1.1
DISEASE BURDEN AND HEALTHCARE MODERNIZATION TO DRIVE MARKET
11.6.2
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
Discover strategic insights and market positions of key players shaping the microfluidics industry.
203
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
12.3
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET
12.4
REVENUE ANALYSIS, 2022–2024
12.5
MARKET SHARE ANALYSIS, 2024
12.6
RANKING OF KEY MARKET PLAYERS
12.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.7.5.1
COMPANY FOOTPRINT
12.7.5.2
REGION FOOTPRINT
12.7.5.3
PRODUCT FOOTPRINT
12.7.5.4
APPLICATION FOOTPRINT
12.7.5.5
END USER FOOTPRINT
12.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.8.1
PROGRESSIVE COMPANIES
12.8.2
RESPONSIVE COMPANIES
12.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.8.5.1
LIST OF KEY STARTUP/SME PLAYERS
12.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
12.9
COMPANY VALUATION & FINANCIAL METRICS
12.10
BRAND/PRODUCT COMPARATIVE ANALYSIS
12.11
COMPETITIVE SCENARIO
12.11.1
PRODUCT LAUNCHES & APPROVALS
12.11.4
OTHER DEVELOPMENTS
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
220
13.1.1
DANAHER CORPORATION
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS OFFERED
13.1.1.3
RECENT DEVELOPMENTS
13.1.1.4.2
STRATEGIC CHOICES
13.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
13.1.4
THERMO FISHER SCIENTIFIC INC.
13.1.5
ABBOTT LABORATORIES
13.1.6
PARKER HANNIFIN CORP
13.1.11
AGILENT TECHNOLOGIES, INC.
13.1.12
BIO-RAD LABORATORIES, INC.
13.1.13
BECTON, DICKINSON AND COMPANY
13.1.14
F. HOFFMANN-LA ROCHE LTD.
13.1.15
STANDARD BIOTOOLS
13.1.16
QUIDELORTHO CORPORATION
13.1.18
DOLOMITE MICROFLUIDICS
13.2.1
NANOSTRING TECHNOLOGIES
13.2.2
INNOVATIVE BIOCHIPS, LLC
14
RESEARCH METHODOLOGY
302
14.2.1
SECONDARY RESEARCH
14.2.1.1
OBJECTIVES OF SECONDARY RESEARCH
14.2.1.2
KEY DATA FROM SECONDARY SOURCES
14.2.2.1
OBJECTIVES OF PRIMARY RESEARCH
14.2.2.2
KEY INDUSTRY INSIGHTS
14.3
MARKET SIZE ESTIMATION METHODOLOGY
14.3.1
BOTTOM-UP APPROACH
14.3.1.1
APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
14.3.1.2
APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
14.3.1.3
APPROACH 3: PRIMARY INTERVIEWS
14.4
MARKET BREAKDOWN AND DATA TRIANGULATION
14.5
MARKET SHARE ASSESSMENT
14.6
RESEARCH ASSUMPTIONS
14.7
RESEARCH LIMITATIONS
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
TABLE 1
MICROFLUIDICS MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2
MICROFLUIDICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 3
DIFFERENT FABRICATION MATERIALS USED
TABLE 4
COMMERCIAL MICROFLUIDIC PCR ASSAYS FOR TB
TABLE 5
COMPARISON OF KEY MATERIALS USED IN MICROFLUIDIC DEVICES
TABLE 6
MICROFLUIDICS MARKET: UNMET NEEDS
TABLE 7
STRATEGIC MOVES BY TIER 1, TIER 2, AND TIER 3 PLAYERS IN MICROFLUIDICS MARKET
TABLE 8
MICROFLUIDICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022–2024
TABLE 9
KEY COMPANIES IMPLEMENTING AI/GENAI IN MICROFLUIDICS MARKET
TABLE 10
US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES
TABLE 11
CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
TABLE 12
EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES
TABLE 13
JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
TABLE 14
CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDIC COMPONENTS, BY MATERIAL
TABLE 21
KEY BUYING CRITERIA FOR MICROFLUIDIC COMPONENTS, BY MATERIAL
TABLE 22
MICROFLUIDICS MARKET: UNMET NEED ANALYSIS
TABLE 23
MICROFLUIDICS MARKET: IMPACT OF PORTER’S FIVE FORCES
TABLE 24
NORTH AMERICA: MACROECONOMIC OUTLOOK
TABLE 25
EUROPE: MACROECONOMIC OUTLOOK
TABLE 26
ASIA PACIFIC: MACROECONOMIC INDICATORS
TABLE 27
LATIN AMERICA: MACROECONOMIC OUTLOOK
TABLE 28
MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
TABLE 29
MICROFLUIDICS MARKET: ROLE IN ECOSYSTEM
TABLE 30
AVERAGE SELLING PRICE RANGE OF MICROFLUIDICS COMPONENTS, BY REGION, 2023–2025 (USD THOUSAND)
TABLE 31
AVERAGE SELLING PRICE TREND OF MICROFLUIDIC COMPONENTS, BY KEY PLAYERS, 2024 (USD)
TABLE 32
IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 33
EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 34
MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2026-2027)
TABLE 35
CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
TABLE 36
CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
TABLE 37
CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
TABLE 38
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 39
TARIFF-INDUCED PRICE INCREASES FOR HEALTHCARE PRODUCTS
TABLE 40
MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 41
MICROFLUIDICS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
MICROFLUIDICS-BASED DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
MICROFLUIDICS-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 44
PCR SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 45
MICROFLUIDIC CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
NEXT-GENERATION SEQUENCING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
DROPLET & PARTICLE PRODUCTION SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 48
OTHER DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 49
MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 50
MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS
TABLE 52
MICROFLUIDIC CHIPS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
FLOW & PRESSURE SENSORS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 54
FLOW & PRESSURE CONTROLLERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 55
MICROFLUIDIC VALVES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
MICROPUMPS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
MICRONEEDLES OFFERED BY KEY PLAYERS
TABLE 58
MICRONEEDLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
OTHER MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 60
MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 61
MATERIAL-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 62
SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 63
PMMA-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
PDMS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 65
COC-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 66
GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 67
OTHER MATERIALS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 68
MICROFLUIDICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 69
MICROFLUIDICS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 70
MICROFLUIDICS MARKET FOR IVD APPLICATION, BY TYPE, 2023–2030 (USD MILLION)
TABLE 71
MICROFLUIDICS MARKET FOR IVD APPLICATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 72
MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 73
MICROFLUIDICS MARKET FOR POCT, BY REGION, 2023–2030 (USD MILLION)
TABLE 74
MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 75
MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 76
MICROFLUIDICS MARKET FOR THERAPEUTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 77
COMPARISON OF MICROFLUIDIC VS. TRADITIONAL API ENCAPSULATION
TABLE 78
MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY REGION, 2023–2030 (USD MILLION)
TABLE 79
OVERVIEW OF WEARABLE MICROFLUIDIC PLATFORMS ACROSS BIOFLUIDS: TARGETS, APPLICATIONS, DETECTION STRATEGIES, AND TRANSLATIONAL STATUS
TABLE 80
MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
TABLE 82
MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2023–2030 (USD MILLION)
TABLE 83
MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 84
MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 85
MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 86
MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 87
KEY ORGAN-ON-CHIP APPLICATIONS
TABLE 88
MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 89
MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2023–2030 (USD MILLION)
TABLE 90
MICROFLUIDICS MARKET FOR MICRODISPENSING, BY REGION, 2023–2030 (USD MILLION)
TABLE 91
MICROFLUIDICS MARKET FOR MICROREACTORS, BY REGION, 2023–2030 (USD MILLION)
TABLE 92
MICROFLUIDICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 93
MICROFLUIDICS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 94
MICROFLUIDICS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 95
MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 96
LEADING MICROFLUIDICS RESEARCH INSTITUTES, BY AREA OF INTEREST
TABLE 97
MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 98
MICROFLUIDICS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 99
NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100
NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 101
NORTH AMERICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 102
NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 103
NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 104
NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 105
NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106
NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
TABLE 107
NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 108
NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 109
NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 110
US: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 111
US: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 112
US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
US: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 114
CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 115
CANADA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 116
CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 117
CANADA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 118
EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119
EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 120
EUROPE: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 121
EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 122
EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 123
EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 124
EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127
EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 128
EUROPE: MICROFLUIDICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 129
GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 130
GERMANY: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 131
GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 133
FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 134
FRANCE: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 135
FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 136
FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 137
UK: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 138
UK: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 139
UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
UK: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 141
ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 142
ITALY: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 143
ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 144
ITALY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 145
SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 146
SPAIN: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 147
SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 149
REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 150
REST OF EUROPE: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 151
REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 152
REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 153
ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 154
ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 155
ASIA PACIFIC: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 156
ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 157
ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 158
ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 159
ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160
ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 164
CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 165
CHINA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 166
CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
CHINA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 168
JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 169
JAPAN: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 170
JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 171
JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 172
INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 173
INDIA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 174
INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
INDIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 176
AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 177
AUSTRALIA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 178
AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179
AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 180
SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 181
SOUTH KOREA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 182
SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 184
REST OF ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 185
REST OF ASIA PACIFIC: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 186
REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187
REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 188
LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 189
LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 190
LATIN AMERICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 191
LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 193
LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 194
LATIN AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 195
LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 199
BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 200
BRAZIL: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 201
BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 203
MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 204
MEXICO: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 205
MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 207
REST OF LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 208
REST OF LATIN AMERICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 209
REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 210
REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 211
MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 212
MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 213
MIDDLE EAST & AFRICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 214
MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 215
MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 216
MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 217
MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 221
MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 222
GCC COUNTRIES: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 223
GCC COUNTRIES: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 224
GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 226
REST OF MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 227
REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023–2030 (USD MILLION)
TABLE 228
REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229
REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023–2030 (USD MILLION)
TABLE 230
OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 231
MICROFLUIDICS MARKET: DEGREE OF COMPETITION
TABLE 232
MICROFLUIDICS MARKET: REGION FOOTPRINT
TABLE 233
MICROFLUIDICS MARKET: PRODUCT FOOTPRINT
TABLE 234
MICROFLUIDICS MARKET: APPLICATION FOOTPRINT
TABLE 235
MICROFLUIDICS MARKET: END USER FOOTPRINT
TABLE 236
MICROFLUIDICS MARKET: LIST OF KEY STARTUP/SME PLAYERS
TABLE 237
MICROFLUIDICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 238
MICROFLUIDICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−NOVEMBER 2025
TABLE 239
MICROFLUIDICS MARKET: DEALS, JANUARY 2022–NOVEMBER 2025
TABLE 240
MICROFLUIDICS MARKET: EXPANSIONS, JANUARY 2022–NOVEMBER 2025
TABLE 241
MICROFLUIDICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025
TABLE 242
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 243
DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 244
DANAHER CORPORATION: DEALS
TABLE 245
DANAHER CORPORATION: EXPANSIONS
TABLE 246
ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 247
ILLUMINA, INC.: PRODUCTS OFFERED
TABLE 248
ILLUMINA, INC.: PRODUCT LAUNCHES
TABLE 249
ILLUMINA, INC.: DEALS
TABLE 250
BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 251
BIOMÉRIEUX: PRODUCTS OFFERED
TABLE 252
BIOMÉRIEUX: PRODUCT LAUNCHES/APPROVALS
TABLE 253
BIOMÉRIEUX: DEALS
TABLE 254
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 255
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 256
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES/APPROVALS
TABLE 257
THERMO FISHER SCIENTIFIC INC.: DEALS
TABLE 258
ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 259
ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 260
PARKER HANNIFIN CORP: COMPANY OVERVIEW
TABLE 261
PARK HANNIFIN CORP: PRODUCTS OFFERED
TABLE 262
SMC CORPORATION: COMPANY OVERVIEW
TABLE 263
SMC CORPORATION: PRODUCTS OFFERED
TABLE 264
SMC CORPORATION: PRODUCT LAUNCHES
TABLE 265
IDEX CORPORATION: COMPANY OVERVIEW
TABLE 266
IDEX CORPORATION: PRODUCTS OFFERED
TABLE 267
IDEX CORPORATION: DEALS
TABLE 268
FORTIVE: COMPANY OVERVIEW
TABLE 269
FORTIVE: PRODUCTS OFFERED
TABLE 270
REVVITY, INC.: COMPANY OVERVIEW
TABLE 271
REVVITY, INC.: PRODUCTS OFFERED
TABLE 272
REVVITY, INC.: DEALS
TABLE 273
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 274
AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 275
AGILENT TECHNOLOGIES, INC. : PRODUCT APPROVALS/LAUNCHES
TABLE 276
AGILENT TECHNOLOGIES, INC.: DEALS
TABLE 277
AGILENT TECHNOLOGIES, INC.: EXPANSIONS
TABLE 278
BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 279
BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 280
BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES
TABLE 281
BIO-RAD LABORATORIES, INC.: DEALS
TABLE 282
BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 283
BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 284
BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES/APPROVALS,
TABLE 285
BECTON, DICKINSON AND COMPANY: DEALS
TABLE 286
BECTON, DICKINSON AND COMPANY: EXPANSIONS
TABLE 287
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 288
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 289
F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES/APPROVALS,
TABLE 290
F. HOFFMANN-LA ROCHE LTD.: DEALS
TABLE 291
STANDARD BIOTOOLS: COMPANY OVERVIEW
TABLE 292
STANDARD BIOTOOLS: PRODUCTS OFFERED
TABLE 293
STANDARD BIOTOOLS: PRODUCT LAUNCHES/APPROVALS
TABLE 294
STANDARD BIOTOOLS: DEALS
TABLE 295
QUIDELORTHO CORPORATION: COMPANY OVERVIEW
TABLE 296
QUIDELORTHO CORPORATION: PRODUCTS OFFERED
TABLE 297
QUIDELORTHO CORPORATION: PRODUCT APPROVALS
TABLE 298
QUIDELORTHO CORPORATION: DEALS
TABLE 299
QUIDELORTHO CORPORATION: EXPANSIONS
TABLE 300
AIGNEP S.P.A.: COMPANY OVERVIEW
TABLE 301
AIGNEP S.P.A.: PRODUCTS OFFERED
TABLE 302
AIGNEP S.P.A.: DEALS
TABLE 303
DOLOMITE MICROFLUIDICS: COMPANY OVERVIEW
TABLE 304
DOLOMITE MICROFLUIDICS: PRODUCTS OFFERED
TABLE 305
DOLOMITE MICROFLUIDICS: PRODUCT LAUNCHES
TABLE 306
DOLOMITE MICROFLUIDICS: DEALS
TABLE 307
DOLOMITE MICROFLUIDICS: OTHER DEVELOPMENTS
TABLE 308
ELVEFLOW: COMPANY OVERVIEW
TABLE 309
ELVEFLOW: PRODUCTS OFFERED
TABLE 310
NANOSTRING TECHNOLOGIES: COMPANY OVERVIEW
TABLE 311
INNOVATIVE BIOCHIPS, LLC: COMPANY OVERVIEW
TABLE 312
FLUIDIC ANALYTICS: COMPANY OVERVIEW
TABLE 313
HORIBA: COMPANY OVERVIEW
TABLE 314
MICRONIT B.V.: COMPANY OVERVIEW
TABLE 315
EMULATE, INC.: COMPANY OVERVIEW
TABLE 316
SPHERE BIO: COMPANY OVERVIEW
TABLE 317
ZEON CORPORATION: COMPANY OVERVIEW
TABLE 318
QIAGEN N.V.: COMPANY OVERVIEW
FIGURE 1
MICROFLUIDICS MARKET SEGMENTATION
FIGURE 3
GLOBAL MICROFLUIDICS MARKET, 2022–2030
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET, 2020–2025
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF MICROFLUIDICS MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS IN MICROFLUIDICS MARKET, 2025–2030
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MICROFLUIDICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8
RISING ADOPTION OF LAB-ON-A-CHIP TECHNOLOGIES TO DRIVE MARKET
FIGURE 9
NORTH AMERICA TO COMMAND LARGEST MARKET SHARE IN 2030
FIGURE 10
NORTH AMERICA AND HOSPITALS & DIAGNOSTIC CENTERS ACCOUNTED FOR LARGEST MARKET SHARES IN 2024
FIGURE 11
CHINA TO REGISTER FASTEST GROWTH FROM 2025 TO 2030
FIGURE 12
MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13
PATENT ANALYSIS FOR MICROFLUIDICS MARKET, JANUARY 2015–NOVEMBER 2025
FIGURE 14
KEY AI USE CASES IN MICROFLUIDICS MARKET
FIGURE 15
US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY
FIGURE 16
CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES
FIGURE 17
EUROPE: REGULATORY PROCESS FOR IVD DEVICES
FIGURE 18
INDIA: REGULATORY PROCESS FOR IVD DEVICES
FIGURE 19
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDIC COMPONENTS, BY MATERIAL
FIGURE 20
KEY BUYING CRITERIA FOR MICROFLUIDIC COMPONENTS, BY MATERIAL
FIGURE 21
MICROFLUIDICS MARKET: UNMET NEED ANALYSIS
FIGURE 22
MICROFLUIDICS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 23
MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 24
MICROFLUIDICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 25
AVERAGE SELLING PRICE TREND OF MICROFLUIDIC COMPONENTS, BY REGION, 2023–2025 (USD)
FIGURE 26
AVERAGE SELLING PRICE TREND OF MICROFLUIDIC COMPONENTS, BY KEY PLAYERS, 2024 (USD)
FIGURE 27
MICROFLUIDICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 28
MICROFLUIDICS MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023 (USD MILLION)
FIGURE 29
NUMBER OF DEALS IN MICROFLUIDICS MARKET, BY KEY PLAYERS, 2019–2023
FIGURE 30
VALUE OF DEALS IN MICROFLUIDICS MARKET, BY KEY PLAYERS, 2019–2023 (USD)
FIGURE 31
NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT
FIGURE 32
ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT
FIGURE 33
REVENUE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2022−2024)
FIGURE 34
MARKET SHARE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2024)
FIGURE 35
RANKING OF KEY PLAYERS IN MICROFLUIDICS MARKET, 2024
FIGURE 36
MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 37
MICROFLUIDICS MARKET: COMPANY FOOTPRINT
FIGURE 38
MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 39
EV/EBITDA OF KEY VENDORS, 2025
FIGURE 40
YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
FIGURE 41
MICROFLUIDICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 42
DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 43
ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 44
BIOMÉRIEUX: COMPANY SNAPSHOT
FIGURE 45
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 46
ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 47
PARKER HANNIFIN CORP: COMPANY SNAPSHOT
FIGURE 48
SMC CORPORATION: COMPANY SNAPSHOT (2024)
FIGURE 49
IDEX CORPORATION: COMPANY SNAPSHOT
FIGURE 50
FORTIVE: COMPANY SNAPSHOT
FIGURE 51
REVVITY, INC.: COMPANY SNAPSHOT
FIGURE 52
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
FIGURE 53
BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 54
BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 55
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 56
STANDARD BIOTOOLS: COMPANY SNAPSHOT
FIGURE 57
QUIDELORTHO CORPORATION: COMPANY SNAPSHOT
FIGURE 58
MICROFLUIDICS MARKET: RESEARCH DATA
FIGURE 59
MICROFLUIDICS MARKET: RESEARCH DESIGN
FIGURE 60
PRIMARY SOURCES
FIGURE 61
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 62
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 63
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 64
MICROFLUIDICS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
FIGURE 65
MICROFLUIDICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 66
MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 67
DATA TRIANGULATION
Vincent
Apr, 2026
How are market size and competitor dynamics shaping growth opportunities in the microfluidics industry?.
Aaron
Apr, 2026
How are microfluidics, nanofluidics, and heat transfer applications shaping the future of biomedical and diagnostic research?.
Liam
Apr, 2026
From a diagnostics buyer perspective, microfluidics looks promising, but integration with existing lab infrastructure is still a concern. How do you see adoption barriers evolving, especially in hospital settings?.
Noah
Apr, 2026
Given the relatively high upfront costs of microfluidic devices, how should decision-makers evaluate ROI, particularly for mid-sized diagnostic labs?.
Elijah
Apr, 2026
From an investor standpoint, the projected CAGR seems moderate compared to other medtech segments. What makes microfluidics a scalable long-term bet?.
Ava
Apr, 2026
How confident should stakeholders be in the reliability and standardization of microfluidic technologies, especially for clinical-grade applications?.
Harper
Apr, 2026
Looking ahead, where do you see the biggest untapped opportunities in the microfluidics market over the next 5–7 years?.
Farrah
May, 2022
Which material segment led the global microfluidics market?.
Kahlill
May, 2022
Which application accounted for the largest microfluidics market share?.
Alex
Nov, 2022
Which technology accounted for the highest share in the microfluidics market?.
James
Nov, 2022
What is the global microfluidics market's expected compound annual growth rate during the forecast period of 2022-2030?.
Philip
Mar, 2022
Which are the key challenges faced by global players of the Microfluidics Market?.